Cross-Sector entity

C-MET

Company
8

All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention AI-based breast cancer detection device, the most common co-covered peer. The tracked stories average 2 original sources each. C-MET appears in 1 tracked Cross-Sector story from March 11, 2026.

1 verified story tracked

Last mentioned: Mar 11, 2026

Entity pulse

Recent coverage · C-MET

1 story
8 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about C-MET

All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention AI-based breast cancer detection device, the most common co-covered peer. The tracked stories average 2 original sources each. C-MET appears in 1 tracked Cross-Sector story from March 11, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering C-MET. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning C-MET 1

Healthcare medical devices Strongly positive 8

Lords Mark and C-MET Partner to Launch AI-Powered Breast Cancer Detection Device

Lords Mark Industries has entered a strategic partnership with the Center for Materials for Electronics Technology (C-MET) to develop a pioneering AI-based breast cancer detection device. This collaboration aims to leverage advanced materials and artificial intelligence to create a non-invasive, highly accurate screening tool for early-stage diagnosis.

2 sources

Source: aninews.in · news.webindia123.com